Teleflex Announces Leadership Change with CFO Retirement
Teleflex Incorporated, a prominent global provider of medical technologies, is undergoing a significant leadership transition as it announces the planned retirement of Thomas E. Powell from his role as Chief Financial Officer (CFO) of the company. Following an impressive career spanning over 13 years, Powell will officially step down from his position effective April 1, 2025.
Succession Plan in Place
Taking over the responsibilities from Powell will be John R. Deren, who is currently the Corporate Vice President and Chief Accounting Officer at Teleflex. His promotion to Executive Vice President and CFO begins on April 2, 2025. Deren’s extensive experience within the company’s finance sector positions him well for this crucial role. In a statement, Powell expressed his appreciation for the opportunity to work alongside the leadership team and highlighted the importance of a smooth transition.
Celebrating Tom Powell's Contributions
Liam Kelly, Teleflex's Chairman, President, and CEO, commended Powell for his pivotal contributions to the company's growth, particularly in driving operating margin expansion. The adjustment of operating margins increased significantly during Powell's tenure, showcasing his expertise and dedication. Kelly noted, "Tom has been a trusted partner in our efforts to build a durable growth company, and his strategic foresight has positioned Teleflex for future success."
Career Path of John R. Deren
John Deren has held various crucial roles within the Teleflex finance organization since he joined the company in 2013. His professional journey includes senior oversight over multiple operations such as Corporate Finance, Supply Chain Finance, Treasury, and Tax. With more than 30 years in financial management and reporting across several public companies, Deren's background includes leadership positions at distinguished firms like Rohm and Haas and Trinseo.
About Teleflex Incorporated
Teleflex is dedicated to improving health outcomes and the quality of life through its innovative medical technologies. The company's portfolio ranges across various critical therapy areas, including anesthesia, emergency medicine, interventional cardiology, surgical, and urology, reinforcing its position as a trusted partner in healthcare worldwide.
Recognized Brands by Teleflex
Teleflex markets a range of well-known medical brands such as Arrow™, Deknatel™, LMA™, and QuikClot™, all unified by a commitment to enhance patient care and streamline healthcare processes. With a focus on purpose-driven innovation and excellence, Teleflex continues to shape the future direction of healthcare.
Continuing Commitment to Healthcare Advancement
By enhancing its leadership team with well-qualified individuals like Deren, Teleflex reaffirms its dedication to empowering the future of healthcare. As the company moves forward, it remains committed to the seamless delivery of innovative solutions that meet the evolving needs of healthcare providers and patients alike.
Frequently Asked Questions
What prompted the retirement of Thomas Powell?
Thomas Powell has decided to retire after over 13 years at Teleflex, leaving a strong legacy of financial leadership.
Who will succeed Thomas Powell as CFO?
John R. Deren will take over as the new Chief Financial Officer effective April 2, 2025.
What are some contributions made by Powell during his tenure?
Powell significantly contributed to the company's operating margin expansion, increasing it by 800 basis points from 2012 to 2024.
What is John Deren's experience prior to joining Teleflex?
Deren has over 30 years of experience in financial management, with previous roles at renowned organizations such as Rohm and Haas and Exelon Generation.
How does Teleflex plan to maintain its success post-transition?
With John Deren's extensive background and experience, Teleflex aims to ensure continuity in its financial leadership and continues to execute its growth strategy effectively.
